Trial intelligence / Profile preview

Lenalidomide Combinations in Elderly Multiple Myeloma

NCT01093196Phase 3Completed

Sponsor
Fondazione EMN Italy
Start
Oct 2009
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Oct 2009; status: completed.

02

Drugs

lenalidomide
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT01093196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01093196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call